SUTRO BIOPHARMA INC. - COMMON STOCK
1.0700
01-May-25 16:45:00
15 minutes delayed
Stocks
+0.0200
+1.90%
Today's range
0.9221 - 1.0700
ISIN
N/A
Source
NASDAQ
-
Sutro Biopharma to Participate in Upcoming Investor Conferences
01 May 2025 16:05:00 By Nasdaq GlobeNewswire
-
28 Apr 2025 16:05:00 By Nasdaq GlobeNewswire
-
15 Mar 2025 18:40:00 By Nasdaq GlobeNewswire
-
Sutro Biopharma Reports Full Year 2024 Financial Results and Business Highlights
13 Mar 2025 16:07:00 By Nasdaq GlobeNewswire
-
13 Mar 2025 16:05:00 By Nasdaq GlobeNewswire
-
Sutro Biopharma to Present at the TD Cowen 45th Annual Health Care Conference
03 Mar 2025 16:05:00 By Nasdaq GlobeNewswire
-
Sutro Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
07 Jan 2025 16:05:03 By Nasdaq GlobeNewswire
-
07 Jan 2025 09:00:00 By Nasdaq GlobeNewswire
-
10 Dec 2024 08:00:00 By Nasdaq GlobeNewswire
-
Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights
13 Nov 2024 16:30:00 By Nasdaq GlobeNewswire
-
04 Nov 2024 16:05:00 By Nasdaq GlobeNewswire
-
01 Nov 2024 08:00:00 By Nasdaq GlobeNewswire
-
Sutro Biopharma Highlights Next-Generation ADC Innovation and Near-term Pipeline at Research Forum
10 Oct 2024 16:05:00 By Nasdaq GlobeNewswire
-
Sutro Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
20 Sep 2024 16:01:00 By Nasdaq GlobeNewswire
-
14 Sep 2024 03:00:00 By Nasdaq GlobeNewswire
-
11 Sep 2024 08:00:00 By Nasdaq GlobeNewswire
-
22 Aug 2024 08:00:00 By Nasdaq GlobeNewswire
-
13 Aug 2024 16:30:00 By Nasdaq GlobeNewswire
-
Sutro Biopharma Appoints Dr. Barbara Leyman as Chief Business Development Officer
09 Jul 2024 08:00:00 By Nasdaq GlobeNewswire
-
13 May 2024 16:30:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >